Journal
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
Volume 320, Issue 6, Pages G1131-G1141Publisher
AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpgi.00331.2020
Keywords
GPCRs; histamine; itch; proteases; visceral hypersensitivity
Categories
Funding
- National Health and Medical Research Council of Australia (NHMRC) [APP1126378]
- NHMRC Australia [1083480, 1139366, 1140297]
- NHMRC Australia Ideas Grant [APP1181448]
- Australian Research Council (ARC) Discovery Early Career Research Award [DE130100223]
- ARC Discovery Project [DP180101395]
- Australian Research Council [DE130100223] Funding Source: Australian Research Council
Ask authors/readers for more resources
This review discusses the underlying causes of chronic visceral pain in patients with IBS, highlighting the role of mediators and receptors that induce itch in the skin acting as gut irritants. Activation of these receptors triggers changes in neuronal excitability, leading to visceral hypersensitivity and pain, suggesting potential therapeutic targets for more effective treatment options.
Chronic abdominal pain is a common clinical condition experienced by patients with irritable bowel syndrome (IBS). A general lack of suitable treatment options for the management of visceral pain is the major contributing factor to the debilitating nature of the disease. Understanding the underlying causes of chronic visceral pain is pivotal to identifying new effective therapies for IBS. This review provides the current evidence, demonstrating that mediators and receptors that induce itch in the skin also act as gut irritants in the gastrointestinal tract. Activation of these receptors triggers specific changes in the neuronal excitability of sensory pathways responsible for the transmission of nociceptive information from the periphery to the central nervous system leading to visceral hypersensitivity and visceral pain. Accumulating evidence points to significant roles of irritant mediators and their receptors in visceral hypersensitivity and thus constitutes potential targets for the development of more effective therapeutic options for IBS.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available